Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases. - Wikidata - awgldk - TriplyDB

Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.

Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.

http://www.wikidata.org/entity/Q33874796

about

Breast cancer brain metastases: the last frontier Role of stereotactic radiosurgery in patients with more than four brain metastases Targeted Therapies for Brain Metastases from Breast Cancer Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context.Brain metastases from breast cancer: lessons from experimental magnetic resonance imaging studies and clinical implications.Brain metastasis in patients with metastatic breast cancer in the real world: a single-institution, retrospective review of 12-year follow-up.Progress in the biological understanding and management of breast cancer-associated central nervous system metastases.Establishment of a Disease-Specific Graded Prognostic Assessment for Hepatocellular Carcinoma Patients with Spinal Metastasis.AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2014.A nomogram for individualized estimation of survival among patients with brain metastasis Validity of two recently-proposed prognostic grading indices for lung, gastro-intestinal, breast and renal cell cancer patients with radiosurgically-treated brain metastases.Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases.Combined primary tumor and extracranial metastasis status as constituent factor of prognostic indices for predicting the overall survival in patients with brain metastases.Systemic treatment after whole-brain radiotherapy may improve survival in RPA class II/III breast cancer patients with brain metastasis.Predicting survival of de novo metastatic breast cancer in Asian women: systematic review and validation study.Local control of brain metastasis: treatment outcome of focal brain treatments in relation to subtypes.Current standards in the management of cerebral metastases.Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases Unsanctifying the sanctuary: challenges and opportunities with brain metastases.Comparison of nine prognostic scores in patients with brain metastases of breast cancer receiving radiotherapy of the brain.Does Graded Prognostic Assessment outperform Recursive Partitioning Analysis in patients with moderate prognosis brain metastases?Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogram.The challenge of durable brain control in patients with brain-only metastases from breast cancer.Assessment of prognostic scores of brain metastases from lung adenocarcinoma with EGFR mutations.Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA).A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience.An institutional retrospective analysis of 93 patients with brain metastases from breast cancer: treatment outcomes, diagnosis-specific prognostic factors.Clinicopathological Factors Related to the Prognosis of Metastatic Breast Cancer Patients after Development of Brain Metastasis.Breast cancer brain metastases: new directions in systemic therapy Clinical implication of Time To Brain Metastasis (TTBM) according to breast cancer subtypes.Controversies in the management of brain metastases Epidemiology and prognosis of brain metastases.Survival following gamma knife radiosurgery for brain metastasis from breast cancer.Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgery Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases Targeted therapies in brain metastases.Assessment of prognostic scores in brain metastases from breast cancer.Optimal management of brain metastases from breast cancer. Issues and considerations.The shifting landscape of metastatic breast cancer to the CNS.Treatment of brain metastases from HER-2-positive breast cancer: current status and new concepts.

P2860

Q26775663-6580F1BD-1E80-459F-840A-3911E853BF49 Q26851819-A9657D1E-E65F-4A0F-83E3-2AE4C89EE6BB Q28068154-A6760F19-FE54-4C1C-908B-45DF5D906D48 Q30238959-7700BE57-C598-4ECF-9419-129E5FE8017C Q30708273-B347C28C-D4B5-4432-AF2A-DDCB16EFFF1B Q31154571-5B25EEF0-5D2B-425D-B17A-D4836591C2A7 Q33777436-DC81D5A4-B15F-476A-B58B-386226589ACB Q33853201-9CF1D3C2-BE14-4C6F-94F5-C9E7C7A959DF Q34042768-A5C48244-B8BF-4626-B542-43A3B41970FF Q34250819-758AEB81-E74F-485C-9D91-6295E437EED2 Q34504595-A04064A5-3B36-4A60-8FD9-68A0F4B9B4F3 Q34581358-8FAA301F-D24D-4CDD-B715-5C7AC315E126 Q34582713-B37E7823-59C1-4BE1-849B-FC6BAA3349E9 Q34762284-A96F5F2D-0B2B-49ED-8158-627E8F059650 Q35138699-B99C7F7E-2968-428E-9BA6-F494ADAD2CF7 Q35237206-9A4B4390-DE47-4312-AEA1-293E6520D6A8 Q35687738-CA6B1008-E988-4735-9381-251BE9B1CB84 Q35721137-AA2D586B-68A5-4ED2-9BD2-B89A8B240E80 Q35788631-A17DDD6E-9BF3-44A1-B206-FE63943D92B0 Q35794600-3E954A61-2738-4EAA-9793-445DD78E3695 Q35960438-B57A4852-5B7A-4F03-9229-9BA4FEB90175 Q36127443-41AE14B8-4D98-4A9B-8B36-7F69E2989851 Q36234038-4EAF6F76-C522-42E8-ABAC-46A7C3EEA657 Q36341131-A97EE763-BEF7-4D27-A677-E089A0E62651 Q36428221-4937CE70-07A3-4C65-A6A9-4D93B17D2BE9 Q36452287-6B6B71CC-51E8-400D-8992-D75BBCDF6FE2 Q36538454-BF402C65-054F-41BA-AA61-D2155573F15C Q36682459-4EC22575-C9B3-465E-B0A6-87B44183ED8F Q36822500-7193EE3F-1D34-404F-B7A5-5803C337DD94 Q36824326-072C9E24-9554-46BC-B3B3-FC18DD5AE6A5 Q36851177-EF39AFFE-CAC1-459A-876F-5ED61D40CE82 Q36851194-43D1D728-0F7C-45D7-9024-9E7E049FDAF2 Q36972484-6EA42DB9-1A11-4980-A346-D1C759EADA11 Q37366712-5CBFD620-6AFE-4F35-8C23-A8334F93F68F Q37398492-305E9ED9-F641-4DB6-862B-20237D3D9DAF Q37491460-D2D0FF44-AAEF-4953-922A-8143FBC52F92 Q37580489-44543193-CCA4-451B-8CBA-02182304CD53 Q38067340-C5196BA7-C622-461E-9E02-D15638F815DD Q38069431-26AA5F85-1BC4-4C1E-A1B4-93B913ADF3B9 Q38155202-C9CE7C7A-9D07-441A-AE30-3BFAAFD0899D

P2860

Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.

http://www.wikidata.org/entity/Q33874796

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Effect of tumor subtype on sur ...... t cancer and brain metastases.

@ast

Effect of tumor subtype on sur ...... t cancer and brain metastases.

@en

type

label

Effect of tumor subtype on sur ...... t cancer and brain metastases.

@ast

Effect of tumor subtype on sur ...... t cancer and brain metastases.

@en

prefLabel

Effect of tumor subtype on sur ...... t cancer and brain metastases.

@ast

Effect of tumor subtype on sur ...... t cancer and brain metastases.

@en

P1433

Q33874796-2C4D6793-30ED-4FFD-8547-F762D9F81AA3

P1476

Q33874796-E3D23B6C-426D-462A-94FE-FEFF725560B0

P2093

Q33874796-22F4AD9A-447E-45A0-A536-893BF0156CD4

Q33874796-230F433D-E55B-4081-AF00-460FDD2893E4

Q33874796-43FC1059-9229-4161-8EBE-991F7BF6A4B2

Q33874796-4B36F048-60E5-4BD3-861B-7BABA7B6DA8F

Q33874796-4C657A9B-F8FB-4673-BB89-0B0A73CED703

Q33874796-5325466C-348C-4FC9-8B01-04B0438688B3

Q33874796-5CADEF18-C93D-4ED8-BB25-DBA88D087FDA

Q33874796-5E5E2F79-51BB-4549-8C7B-8D43EE66274C

Q33874796-6E80AD5C-0E5F-4474-A7B0-3176E9736E1F

Q33874796-70CB9993-0483-40ED-9DDB-AAF3306E98EB

P2860

Q33874796-00E53BC5-1FD7-46B6-B738-F968CB724A5A

Q33874796-04B6B755-F66A-46F8-A61F-85B171791C5D

Q33874796-0A022059-4589-4C2C-B0FF-7D08E8C2AD95

Q33874796-1267C593-9734-4C44-805F-DD0CF5C1A7B7

Q33874796-12FE9B2F-36B8-4002-924B-04D447DFF039

Q33874796-133C2BAC-1919-48EC-B8D0-7121DDC5C935

Q33874796-1817AEFC-02DA-471F-BE58-AD310713CDF2

Q33874796-1A5695D8-1179-4488-884B-3AD7F13C71E9

Q33874796-1BA97B85-3816-41C1-BBC5-ED6D61EC32C3

Q33874796-1BAFFFDD-2A9A-419E-81D0-177E8039AC98

P304

Q33874796-EB4AB412-97B6-4278-86E3-E917F0DBB558

P31

Q33874796-9C243B38-61A0-454D-A3B8-CEAA002B5AED

P356

Q33874796-3BBA787C-348A-4379-BB48-4A2D27CEDD8F

P407

Q33874796-3BFD112B-0136-49AF-B73E-A8A62B03ADBE

P433

Q33874796-C43F5FB3-0AF7-42CD-98F4-5E696EF10A2E

P478

Q33874796-FCE0E7CB-B893-40FB-ABAF-6178F72EA206

P50

Q33874796-6E73D797-1BD1-4560-93A5-3CB8A9DEAC54

Q33874796-75518C7F-4346-4E35-A3C0-F74DE6F41BE6

Q33874796-E90B00CC-1796-4FD7-8047-CF23C6A27DBE

P577

Q33874796-B87CFCAF-4F2F-4BB7-81DD-D8FAC33C12CE

P5875

Q33874796-B99BE8D2-9622-4E91-847D-9D2ABC713D70

P698

Q33874796-3C40AF78-84B4-420A-B5F3-151D5AC154C8

P921

Q33874796-6A7536C6-3EF9-41C6-A0B9-95FF9D37CE77

P932

Q33874796-4AEC2A9C-8DE9-4081-A5D4-53339AEB1B91

P356

J.IJROBP.2011.02.027

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Effect of tumor subtype on sur ...... st cancer and brain metastases

@en

P2093

Amit Bhatt

http://www.w3.org/2001/XMLSchema#string

Ashley W Jensen

http://www.w3.org/2001/XMLSchema#string

Christina Maria Sperduto

http://www.w3.org/2001/XMLSchema#string

David Roberge

http://www.w3.org/2001/XMLSchema#string

John B Fiveash

http://www.w3.org/2001/XMLSchema#string

John Suh

http://www.w3.org/2001/XMLSchema#string

Jonathan P S Knisely

http://www.w3.org/2001/XMLSchema#string

Laurie E Gaspar

http://www.w3.org/2001/XMLSchema#string

Nancy Lin

http://www.w3.org/2001/XMLSchema#string

Norbert Kased

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Cancer statistics, 2010

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Molecular portraits of human breast tumours

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Gamma knife surgery for the treatment of intracranial metastases from breast cancer.

Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases.

Stereotactic radiosurgery for multiple brain metastases from breast carcinoma.

Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.

Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.

P304

2111-2117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJROBP.2011.02.027

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P50

John P. Kirkpatrick

P577

2011-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51055417

http://www.w3.org/2001/XMLSchema#string

P698

21497451

http://www.w3.org/2001/XMLSchema#string

P921

P932

3172400

http://www.w3.org/2001/XMLSchema#string